Global pharmaceutical company secures summary judgment on all claims in wrongful death action involving clinical trial participant
Client(s) Global pharmaceutical company
Jones Day successfully defended a global pharmaceutical manufacturer in a wrongful death suit filed by the parents of a young woman with Acute Lymphoblastic Leukemia who died in a clinical trial for CAR-T cell therapy. Following fact and expert discovery involving nine experts, Jones Day secured summary judgment on all claims in favor of its client. In addition to dismissing all claims against Jones Day’s client, the reasoned decision by the Chief Judge of the District Court for the Southern District of Texas added valuable clarity to the application of the learned intermediary doctrine to clinical trials.
